Medical Care
Global OTC Antihistamine Market Research Report 2025
- May 12, 25
- ID: 236213
- Pages: 110
- Figures: 109
- Views: 1
The global market for OTC Antihistamine was valued at US$ 145760 million in the year 2024 and is projected to reach a revised size of US$ 255990 million by 2031, growing at a CAGR of 8.5% during the forecast period.
Over-the-counter (OTC) antihistamines are medicines that treat allergy symptoms. OTC means you can buy them at a store, without a doctor"s prescription. They are available as pills, liquids, nasal sprays, gels, and eyedrops. There are two types of OTC antihistamines: first-generation and second-generation.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for OTC Antihistamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Antihistamine.
The OTC Antihistamine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global OTC Antihistamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Antihistamine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Pfizer
Bayer
Teva
Cadila Pharmaceuticals
PAI Pharma
Dr. Reddy's Laboratories
Johnson & Johnson
SANOFI
PL Developments
APOTEX
Morepen
Ultratech India
Vasudha Pharma Chem
Hetero Drugs
Mylan
Changzhou Yabang
Shaanxi Hanjiang
Inke, S.A.
Argon Drugs
Covis Pharma
Segment by Type
Oral Solution
Tablet
Capsule
Segment by Application
Hospital
Clinic
Drug Store
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Antihistamine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Over-the-counter (OTC) antihistamines are medicines that treat allergy symptoms. OTC means you can buy them at a store, without a doctor"s prescription. They are available as pills, liquids, nasal sprays, gels, and eyedrops. There are two types of OTC antihistamines: first-generation and second-generation.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for OTC Antihistamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Antihistamine.
The OTC Antihistamine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global OTC Antihistamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Antihistamine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Pfizer
Bayer
Teva
Cadila Pharmaceuticals
PAI Pharma
Dr. Reddy's Laboratories
Johnson & Johnson
SANOFI
PL Developments
APOTEX
Morepen
Ultratech India
Vasudha Pharma Chem
Hetero Drugs
Mylan
Changzhou Yabang
Shaanxi Hanjiang
Inke, S.A.
Argon Drugs
Covis Pharma
Segment by Type
Oral Solution
Tablet
Capsule
Segment by Application
Hospital
Clinic
Drug Store
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Antihistamine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Antihistamine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral Solution
1.2.3 Tablet
1.2.4 Capsule
1.3 Market by Application
1.3.1 Global OTC Antihistamine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Store
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Antihistamine Market Perspective (2020-2031)
2.2 Global OTC Antihistamine Growth Trends by Region
2.2.1 Global OTC Antihistamine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 OTC Antihistamine Historic Market Size by Region (2020-2025)
2.2.3 OTC Antihistamine Forecasted Market Size by Region (2026-2031)
2.3 OTC Antihistamine Market Dynamics
2.3.1 OTC Antihistamine Industry Trends
2.3.2 OTC Antihistamine Market Drivers
2.3.3 OTC Antihistamine Market Challenges
2.3.4 OTC Antihistamine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Antihistamine Players by Revenue
3.1.1 Global Top OTC Antihistamine Players by Revenue (2020-2025)
3.1.2 Global OTC Antihistamine Revenue Market Share by Players (2020-2025)
3.2 Global OTC Antihistamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by OTC Antihistamine Revenue
3.4 Global OTC Antihistamine Market Concentration Ratio
3.4.1 Global OTC Antihistamine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Antihistamine Revenue in 2024
3.5 Global Key Players of OTC Antihistamine Head office and Area Served
3.6 Global Key Players of OTC Antihistamine, Product and Application
3.7 Global Key Players of OTC Antihistamine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Antihistamine Breakdown Data by Type
4.1 Global OTC Antihistamine Historic Market Size by Type (2020-2025)
4.2 Global OTC Antihistamine Forecasted Market Size by Type (2026-2031)
5 OTC Antihistamine Breakdown Data by Application
5.1 Global OTC Antihistamine Historic Market Size by Application (2020-2025)
5.2 Global OTC Antihistamine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America OTC Antihistamine Market Size (2020-2031)
6.2 North America OTC Antihistamine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America OTC Antihistamine Market Size by Country (2020-2025)
6.4 North America OTC Antihistamine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Antihistamine Market Size (2020-2031)
7.2 Europe OTC Antihistamine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe OTC Antihistamine Market Size by Country (2020-2025)
7.4 Europe OTC Antihistamine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Antihistamine Market Size (2020-2031)
8.2 Asia-Pacific OTC Antihistamine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific OTC Antihistamine Market Size by Region (2020-2025)
8.4 Asia-Pacific OTC Antihistamine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Antihistamine Market Size (2020-2031)
9.2 Latin America OTC Antihistamine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America OTC Antihistamine Market Size by Country (2020-2025)
9.4 Latin America OTC Antihistamine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Antihistamine Market Size (2020-2031)
10.2 Middle East & Africa OTC Antihistamine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa OTC Antihistamine Market Size by Country (2020-2025)
10.4 Middle East & Africa OTC Antihistamine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck OTC Antihistamine Introduction
11.1.4 Merck Revenue in OTC Antihistamine Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer OTC Antihistamine Introduction
11.2.4 Pfizer Revenue in OTC Antihistamine Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer OTC Antihistamine Introduction
11.3.4 Bayer Revenue in OTC Antihistamine Business (2020-2025)
11.3.5 Bayer Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva OTC Antihistamine Introduction
11.4.4 Teva Revenue in OTC Antihistamine Business (2020-2025)
11.4.5 Teva Recent Development
11.5 Cadila Pharmaceuticals
11.5.1 Cadila Pharmaceuticals Company Details
11.5.2 Cadila Pharmaceuticals Business Overview
11.5.3 Cadila Pharmaceuticals OTC Antihistamine Introduction
11.5.4 Cadila Pharmaceuticals Revenue in OTC Antihistamine Business (2020-2025)
11.5.5 Cadila Pharmaceuticals Recent Development
11.6 PAI Pharma
11.6.1 PAI Pharma Company Details
11.6.2 PAI Pharma Business Overview
11.6.3 PAI Pharma OTC Antihistamine Introduction
11.6.4 PAI Pharma Revenue in OTC Antihistamine Business (2020-2025)
11.6.5 PAI Pharma Recent Development
11.7 Dr. Reddy's Laboratories
11.7.1 Dr. Reddy's Laboratories Company Details
11.7.2 Dr. Reddy's Laboratories Business Overview
11.7.3 Dr. Reddy's Laboratories OTC Antihistamine Introduction
11.7.4 Dr. Reddy's Laboratories Revenue in OTC Antihistamine Business (2020-2025)
11.7.5 Dr. Reddy's Laboratories Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson OTC Antihistamine Introduction
11.8.4 Johnson & Johnson Revenue in OTC Antihistamine Business (2020-2025)
11.8.5 Johnson & Johnson Recent Development
11.9 SANOFI
11.9.1 SANOFI Company Details
11.9.2 SANOFI Business Overview
11.9.3 SANOFI OTC Antihistamine Introduction
11.9.4 SANOFI Revenue in OTC Antihistamine Business (2020-2025)
11.9.5 SANOFI Recent Development
11.10 PL Developments
11.10.1 PL Developments Company Details
11.10.2 PL Developments Business Overview
11.10.3 PL Developments OTC Antihistamine Introduction
11.10.4 PL Developments Revenue in OTC Antihistamine Business (2020-2025)
11.10.5 PL Developments Recent Development
11.11 APOTEX
11.11.1 APOTEX Company Details
11.11.2 APOTEX Business Overview
11.11.3 APOTEX OTC Antihistamine Introduction
11.11.4 APOTEX Revenue in OTC Antihistamine Business (2020-2025)
11.11.5 APOTEX Recent Development
11.12 Morepen
11.12.1 Morepen Company Details
11.12.2 Morepen Business Overview
11.12.3 Morepen OTC Antihistamine Introduction
11.12.4 Morepen Revenue in OTC Antihistamine Business (2020-2025)
11.12.5 Morepen Recent Development
11.13 Ultratech India
11.13.1 Ultratech India Company Details
11.13.2 Ultratech India Business Overview
11.13.3 Ultratech India OTC Antihistamine Introduction
11.13.4 Ultratech India Revenue in OTC Antihistamine Business (2020-2025)
11.13.5 Ultratech India Recent Development
11.14 Vasudha Pharma Chem
11.14.1 Vasudha Pharma Chem Company Details
11.14.2 Vasudha Pharma Chem Business Overview
11.14.3 Vasudha Pharma Chem OTC Antihistamine Introduction
11.14.4 Vasudha Pharma Chem Revenue in OTC Antihistamine Business (2020-2025)
11.14.5 Vasudha Pharma Chem Recent Development
11.15 Hetero Drugs
11.15.1 Hetero Drugs Company Details
11.15.2 Hetero Drugs Business Overview
11.15.3 Hetero Drugs OTC Antihistamine Introduction
11.15.4 Hetero Drugs Revenue in OTC Antihistamine Business (2020-2025)
11.15.5 Hetero Drugs Recent Development
11.16 Mylan
11.16.1 Mylan Company Details
11.16.2 Mylan Business Overview
11.16.3 Mylan OTC Antihistamine Introduction
11.16.4 Mylan Revenue in OTC Antihistamine Business (2020-2025)
11.16.5 Mylan Recent Development
11.17 Changzhou Yabang
11.17.1 Changzhou Yabang Company Details
11.17.2 Changzhou Yabang Business Overview
11.17.3 Changzhou Yabang OTC Antihistamine Introduction
11.17.4 Changzhou Yabang Revenue in OTC Antihistamine Business (2020-2025)
11.17.5 Changzhou Yabang Recent Development
11.18 Shaanxi Hanjiang
11.18.1 Shaanxi Hanjiang Company Details
11.18.2 Shaanxi Hanjiang Business Overview
11.18.3 Shaanxi Hanjiang OTC Antihistamine Introduction
11.18.4 Shaanxi Hanjiang Revenue in OTC Antihistamine Business (2020-2025)
11.18.5 Shaanxi Hanjiang Recent Development
11.19 Inke, S.A.
11.19.1 Inke, S.A. Company Details
11.19.2 Inke, S.A. Business Overview
11.19.3 Inke, S.A. OTC Antihistamine Introduction
11.19.4 Inke, S.A. Revenue in OTC Antihistamine Business (2020-2025)
11.19.5 Inke, S.A. Recent Development
11.20 Argon Drugs
11.20.1 Argon Drugs Company Details
11.20.2 Argon Drugs Business Overview
11.20.3 Argon Drugs OTC Antihistamine Introduction
11.20.4 Argon Drugs Revenue in OTC Antihistamine Business (2020-2025)
11.20.5 Argon Drugs Recent Development
11.21 Covis Pharma
11.21.1 Covis Pharma Company Details
11.21.2 Covis Pharma Business Overview
11.21.3 Covis Pharma OTC Antihistamine Introduction
11.21.4 Covis Pharma Revenue in OTC Antihistamine Business (2020-2025)
11.21.5 Covis Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Antihistamine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral Solution
1.2.3 Tablet
1.2.4 Capsule
1.3 Market by Application
1.3.1 Global OTC Antihistamine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Store
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Antihistamine Market Perspective (2020-2031)
2.2 Global OTC Antihistamine Growth Trends by Region
2.2.1 Global OTC Antihistamine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 OTC Antihistamine Historic Market Size by Region (2020-2025)
2.2.3 OTC Antihistamine Forecasted Market Size by Region (2026-2031)
2.3 OTC Antihistamine Market Dynamics
2.3.1 OTC Antihistamine Industry Trends
2.3.2 OTC Antihistamine Market Drivers
2.3.3 OTC Antihistamine Market Challenges
2.3.4 OTC Antihistamine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Antihistamine Players by Revenue
3.1.1 Global Top OTC Antihistamine Players by Revenue (2020-2025)
3.1.2 Global OTC Antihistamine Revenue Market Share by Players (2020-2025)
3.2 Global OTC Antihistamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by OTC Antihistamine Revenue
3.4 Global OTC Antihistamine Market Concentration Ratio
3.4.1 Global OTC Antihistamine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Antihistamine Revenue in 2024
3.5 Global Key Players of OTC Antihistamine Head office and Area Served
3.6 Global Key Players of OTC Antihistamine, Product and Application
3.7 Global Key Players of OTC Antihistamine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Antihistamine Breakdown Data by Type
4.1 Global OTC Antihistamine Historic Market Size by Type (2020-2025)
4.2 Global OTC Antihistamine Forecasted Market Size by Type (2026-2031)
5 OTC Antihistamine Breakdown Data by Application
5.1 Global OTC Antihistamine Historic Market Size by Application (2020-2025)
5.2 Global OTC Antihistamine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America OTC Antihistamine Market Size (2020-2031)
6.2 North America OTC Antihistamine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America OTC Antihistamine Market Size by Country (2020-2025)
6.4 North America OTC Antihistamine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Antihistamine Market Size (2020-2031)
7.2 Europe OTC Antihistamine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe OTC Antihistamine Market Size by Country (2020-2025)
7.4 Europe OTC Antihistamine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Antihistamine Market Size (2020-2031)
8.2 Asia-Pacific OTC Antihistamine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific OTC Antihistamine Market Size by Region (2020-2025)
8.4 Asia-Pacific OTC Antihistamine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Antihistamine Market Size (2020-2031)
9.2 Latin America OTC Antihistamine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America OTC Antihistamine Market Size by Country (2020-2025)
9.4 Latin America OTC Antihistamine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Antihistamine Market Size (2020-2031)
10.2 Middle East & Africa OTC Antihistamine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa OTC Antihistamine Market Size by Country (2020-2025)
10.4 Middle East & Africa OTC Antihistamine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck OTC Antihistamine Introduction
11.1.4 Merck Revenue in OTC Antihistamine Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer OTC Antihistamine Introduction
11.2.4 Pfizer Revenue in OTC Antihistamine Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer OTC Antihistamine Introduction
11.3.4 Bayer Revenue in OTC Antihistamine Business (2020-2025)
11.3.5 Bayer Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva OTC Antihistamine Introduction
11.4.4 Teva Revenue in OTC Antihistamine Business (2020-2025)
11.4.5 Teva Recent Development
11.5 Cadila Pharmaceuticals
11.5.1 Cadila Pharmaceuticals Company Details
11.5.2 Cadila Pharmaceuticals Business Overview
11.5.3 Cadila Pharmaceuticals OTC Antihistamine Introduction
11.5.4 Cadila Pharmaceuticals Revenue in OTC Antihistamine Business (2020-2025)
11.5.5 Cadila Pharmaceuticals Recent Development
11.6 PAI Pharma
11.6.1 PAI Pharma Company Details
11.6.2 PAI Pharma Business Overview
11.6.3 PAI Pharma OTC Antihistamine Introduction
11.6.4 PAI Pharma Revenue in OTC Antihistamine Business (2020-2025)
11.6.5 PAI Pharma Recent Development
11.7 Dr. Reddy's Laboratories
11.7.1 Dr. Reddy's Laboratories Company Details
11.7.2 Dr. Reddy's Laboratories Business Overview
11.7.3 Dr. Reddy's Laboratories OTC Antihistamine Introduction
11.7.4 Dr. Reddy's Laboratories Revenue in OTC Antihistamine Business (2020-2025)
11.7.5 Dr. Reddy's Laboratories Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson OTC Antihistamine Introduction
11.8.4 Johnson & Johnson Revenue in OTC Antihistamine Business (2020-2025)
11.8.5 Johnson & Johnson Recent Development
11.9 SANOFI
11.9.1 SANOFI Company Details
11.9.2 SANOFI Business Overview
11.9.3 SANOFI OTC Antihistamine Introduction
11.9.4 SANOFI Revenue in OTC Antihistamine Business (2020-2025)
11.9.5 SANOFI Recent Development
11.10 PL Developments
11.10.1 PL Developments Company Details
11.10.2 PL Developments Business Overview
11.10.3 PL Developments OTC Antihistamine Introduction
11.10.4 PL Developments Revenue in OTC Antihistamine Business (2020-2025)
11.10.5 PL Developments Recent Development
11.11 APOTEX
11.11.1 APOTEX Company Details
11.11.2 APOTEX Business Overview
11.11.3 APOTEX OTC Antihistamine Introduction
11.11.4 APOTEX Revenue in OTC Antihistamine Business (2020-2025)
11.11.5 APOTEX Recent Development
11.12 Morepen
11.12.1 Morepen Company Details
11.12.2 Morepen Business Overview
11.12.3 Morepen OTC Antihistamine Introduction
11.12.4 Morepen Revenue in OTC Antihistamine Business (2020-2025)
11.12.5 Morepen Recent Development
11.13 Ultratech India
11.13.1 Ultratech India Company Details
11.13.2 Ultratech India Business Overview
11.13.3 Ultratech India OTC Antihistamine Introduction
11.13.4 Ultratech India Revenue in OTC Antihistamine Business (2020-2025)
11.13.5 Ultratech India Recent Development
11.14 Vasudha Pharma Chem
11.14.1 Vasudha Pharma Chem Company Details
11.14.2 Vasudha Pharma Chem Business Overview
11.14.3 Vasudha Pharma Chem OTC Antihistamine Introduction
11.14.4 Vasudha Pharma Chem Revenue in OTC Antihistamine Business (2020-2025)
11.14.5 Vasudha Pharma Chem Recent Development
11.15 Hetero Drugs
11.15.1 Hetero Drugs Company Details
11.15.2 Hetero Drugs Business Overview
11.15.3 Hetero Drugs OTC Antihistamine Introduction
11.15.4 Hetero Drugs Revenue in OTC Antihistamine Business (2020-2025)
11.15.5 Hetero Drugs Recent Development
11.16 Mylan
11.16.1 Mylan Company Details
11.16.2 Mylan Business Overview
11.16.3 Mylan OTC Antihistamine Introduction
11.16.4 Mylan Revenue in OTC Antihistamine Business (2020-2025)
11.16.5 Mylan Recent Development
11.17 Changzhou Yabang
11.17.1 Changzhou Yabang Company Details
11.17.2 Changzhou Yabang Business Overview
11.17.3 Changzhou Yabang OTC Antihistamine Introduction
11.17.4 Changzhou Yabang Revenue in OTC Antihistamine Business (2020-2025)
11.17.5 Changzhou Yabang Recent Development
11.18 Shaanxi Hanjiang
11.18.1 Shaanxi Hanjiang Company Details
11.18.2 Shaanxi Hanjiang Business Overview
11.18.3 Shaanxi Hanjiang OTC Antihistamine Introduction
11.18.4 Shaanxi Hanjiang Revenue in OTC Antihistamine Business (2020-2025)
11.18.5 Shaanxi Hanjiang Recent Development
11.19 Inke, S.A.
11.19.1 Inke, S.A. Company Details
11.19.2 Inke, S.A. Business Overview
11.19.3 Inke, S.A. OTC Antihistamine Introduction
11.19.4 Inke, S.A. Revenue in OTC Antihistamine Business (2020-2025)
11.19.5 Inke, S.A. Recent Development
11.20 Argon Drugs
11.20.1 Argon Drugs Company Details
11.20.2 Argon Drugs Business Overview
11.20.3 Argon Drugs OTC Antihistamine Introduction
11.20.4 Argon Drugs Revenue in OTC Antihistamine Business (2020-2025)
11.20.5 Argon Drugs Recent Development
11.21 Covis Pharma
11.21.1 Covis Pharma Company Details
11.21.2 Covis Pharma Business Overview
11.21.3 Covis Pharma OTC Antihistamine Introduction
11.21.4 Covis Pharma Revenue in OTC Antihistamine Business (2020-2025)
11.21.5 Covis Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global OTC Antihistamine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral Solution
Table 3. Key Players of Tablet
Table 4. Key Players of Capsule
Table 5. Global OTC Antihistamine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global OTC Antihistamine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global OTC Antihistamine Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global OTC Antihistamine Market Share by Region (2020-2025)
Table 9. Global OTC Antihistamine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global OTC Antihistamine Market Share by Region (2026-2031)
Table 11. OTC Antihistamine Market Trends
Table 12. OTC Antihistamine Market Drivers
Table 13. OTC Antihistamine Market Challenges
Table 14. OTC Antihistamine Market Restraints
Table 15. Global OTC Antihistamine Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global OTC Antihistamine Market Share by Players (2020-2025)
Table 17. Global Top OTC Antihistamine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Antihistamine as of 2024)
Table 18. Ranking of Global Top OTC Antihistamine Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by OTC Antihistamine Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of OTC Antihistamine, Headquarters and Area Served
Table 21. Global Key Players of OTC Antihistamine, Product and Application
Table 22. Global Key Players of OTC Antihistamine, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global OTC Antihistamine Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global OTC Antihistamine Revenue Market Share by Type (2020-2025)
Table 26. Global OTC Antihistamine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global OTC Antihistamine Revenue Market Share by Type (2026-2031)
Table 28. Global OTC Antihistamine Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global OTC Antihistamine Revenue Market Share by Application (2020-2025)
Table 30. Global OTC Antihistamine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global OTC Antihistamine Revenue Market Share by Application (2026-2031)
Table 32. North America OTC Antihistamine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America OTC Antihistamine Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America OTC Antihistamine Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe OTC Antihistamine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe OTC Antihistamine Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe OTC Antihistamine Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific OTC Antihistamine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific OTC Antihistamine Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific OTC Antihistamine Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America OTC Antihistamine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America OTC Antihistamine Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America OTC Antihistamine Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa OTC Antihistamine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa OTC Antihistamine Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa OTC Antihistamine Market Size by Country (2026-2031) & (US$ Million)
Table 47. Merck Company Details
Table 48. Merck Business Overview
Table 49. Merck OTC Antihistamine Product
Table 50. Merck Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 51. Merck Recent Development
Table 52. Pfizer Company Details
Table 53. Pfizer Business Overview
Table 54. Pfizer OTC Antihistamine Product
Table 55. Pfizer Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Bayer Company Details
Table 58. Bayer Business Overview
Table 59. Bayer OTC Antihistamine Product
Table 60. Bayer Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 61. Bayer Recent Development
Table 62. Teva Company Details
Table 63. Teva Business Overview
Table 64. Teva OTC Antihistamine Product
Table 65. Teva Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 66. Teva Recent Development
Table 67. Cadila Pharmaceuticals Company Details
Table 68. Cadila Pharmaceuticals Business Overview
Table 69. Cadila Pharmaceuticals OTC Antihistamine Product
Table 70. Cadila Pharmaceuticals Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 71. Cadila Pharmaceuticals Recent Development
Table 72. PAI Pharma Company Details
Table 73. PAI Pharma Business Overview
Table 74. PAI Pharma OTC Antihistamine Product
Table 75. PAI Pharma Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 76. PAI Pharma Recent Development
Table 77. Dr. Reddy's Laboratories Company Details
Table 78. Dr. Reddy's Laboratories Business Overview
Table 79. Dr. Reddy's Laboratories OTC Antihistamine Product
Table 80. Dr. Reddy's Laboratories Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 81. Dr. Reddy's Laboratories Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson OTC Antihistamine Product
Table 85. Johnson & Johnson Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. SANOFI Company Details
Table 88. SANOFI Business Overview
Table 89. SANOFI OTC Antihistamine Product
Table 90. SANOFI Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 91. SANOFI Recent Development
Table 92. PL Developments Company Details
Table 93. PL Developments Business Overview
Table 94. PL Developments OTC Antihistamine Product
Table 95. PL Developments Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 96. PL Developments Recent Development
Table 97. APOTEX Company Details
Table 98. APOTEX Business Overview
Table 99. APOTEX OTC Antihistamine Product
Table 100. APOTEX Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 101. APOTEX Recent Development
Table 102. Morepen Company Details
Table 103. Morepen Business Overview
Table 104. Morepen OTC Antihistamine Product
Table 105. Morepen Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 106. Morepen Recent Development
Table 107. Ultratech India Company Details
Table 108. Ultratech India Business Overview
Table 109. Ultratech India OTC Antihistamine Product
Table 110. Ultratech India Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 111. Ultratech India Recent Development
Table 112. Vasudha Pharma Chem Company Details
Table 113. Vasudha Pharma Chem Business Overview
Table 114. Vasudha Pharma Chem OTC Antihistamine Product
Table 115. Vasudha Pharma Chem Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 116. Vasudha Pharma Chem Recent Development
Table 117. Hetero Drugs Company Details
Table 118. Hetero Drugs Business Overview
Table 119. Hetero Drugs OTC Antihistamine Product
Table 120. Hetero Drugs Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 121. Hetero Drugs Recent Development
Table 122. Mylan Company Details
Table 123. Mylan Business Overview
Table 124. Mylan OTC Antihistamine Product
Table 125. Mylan Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 126. Mylan Recent Development
Table 127. Changzhou Yabang Company Details
Table 128. Changzhou Yabang Business Overview
Table 129. Changzhou Yabang OTC Antihistamine Product
Table 130. Changzhou Yabang Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 131. Changzhou Yabang Recent Development
Table 132. Shaanxi Hanjiang Company Details
Table 133. Shaanxi Hanjiang Business Overview
Table 134. Shaanxi Hanjiang OTC Antihistamine Product
Table 135. Shaanxi Hanjiang Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 136. Shaanxi Hanjiang Recent Development
Table 137. Inke, S.A. Company Details
Table 138. Inke, S.A. Business Overview
Table 139. Inke, S.A. OTC Antihistamine Product
Table 140. Inke, S.A. Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 141. Inke, S.A. Recent Development
Table 142. Argon Drugs Company Details
Table 143. Argon Drugs Business Overview
Table 144. Argon Drugs OTC Antihistamine Product
Table 145. Argon Drugs Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 146. Argon Drugs Recent Development
Table 147. Covis Pharma Company Details
Table 148. Covis Pharma Business Overview
Table 149. Covis Pharma OTC Antihistamine Product
Table 150. Covis Pharma Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 151. Covis Pharma Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
Table 155. Authors List of This Report
List of Figures
Figure 1. OTC Antihistamine Picture
Figure 2. Global OTC Antihistamine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global OTC Antihistamine Market Share by Type: 2024 VS 2031
Figure 4. Oral Solution Features
Figure 5. Tablet Features
Figure 6. Capsule Features
Figure 7. Global OTC Antihistamine Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global OTC Antihistamine Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Drug Store Case Studies
Figure 12. OTC Antihistamine Report Years Considered
Figure 13. Global OTC Antihistamine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global OTC Antihistamine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global OTC Antihistamine Market Share by Region: 2024 VS 2031
Figure 16. Global OTC Antihistamine Market Share by Players in 2024
Figure 17. Global Top OTC Antihistamine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Antihistamine as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by OTC Antihistamine Revenue in 2024
Figure 19. North America OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America OTC Antihistamine Market Share by Country (2020-2031)
Figure 21. United States OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe OTC Antihistamine Market Share by Country (2020-2031)
Figure 25. Germany OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific OTC Antihistamine Market Share by Region (2020-2031)
Figure 33. China OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America OTC Antihistamine Market Share by Country (2020-2031)
Figure 41. Mexico OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa OTC Antihistamine Market Share by Country (2020-2031)
Figure 45. Turkey OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Merck Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 50. Bayer Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 51. Teva Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 52. Cadila Pharmaceuticals Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 53. PAI Pharma Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 54. Dr. Reddy's Laboratories Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 55. Johnson & Johnson Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 56. SANOFI Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 57. PL Developments Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 58. APOTEX Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 59. Morepen Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 60. Ultratech India Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 61. Vasudha Pharma Chem Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 62. Hetero Drugs Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 63. Mylan Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 64. Changzhou Yabang Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 65. Shaanxi Hanjiang Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 66. Inke, S.A. Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 67. Argon Drugs Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 68. Covis Pharma Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Table 1. Global OTC Antihistamine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral Solution
Table 3. Key Players of Tablet
Table 4. Key Players of Capsule
Table 5. Global OTC Antihistamine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global OTC Antihistamine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global OTC Antihistamine Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global OTC Antihistamine Market Share by Region (2020-2025)
Table 9. Global OTC Antihistamine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global OTC Antihistamine Market Share by Region (2026-2031)
Table 11. OTC Antihistamine Market Trends
Table 12. OTC Antihistamine Market Drivers
Table 13. OTC Antihistamine Market Challenges
Table 14. OTC Antihistamine Market Restraints
Table 15. Global OTC Antihistamine Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global OTC Antihistamine Market Share by Players (2020-2025)
Table 17. Global Top OTC Antihistamine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Antihistamine as of 2024)
Table 18. Ranking of Global Top OTC Antihistamine Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by OTC Antihistamine Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of OTC Antihistamine, Headquarters and Area Served
Table 21. Global Key Players of OTC Antihistamine, Product and Application
Table 22. Global Key Players of OTC Antihistamine, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global OTC Antihistamine Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global OTC Antihistamine Revenue Market Share by Type (2020-2025)
Table 26. Global OTC Antihistamine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global OTC Antihistamine Revenue Market Share by Type (2026-2031)
Table 28. Global OTC Antihistamine Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global OTC Antihistamine Revenue Market Share by Application (2020-2025)
Table 30. Global OTC Antihistamine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global OTC Antihistamine Revenue Market Share by Application (2026-2031)
Table 32. North America OTC Antihistamine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America OTC Antihistamine Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America OTC Antihistamine Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe OTC Antihistamine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe OTC Antihistamine Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe OTC Antihistamine Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific OTC Antihistamine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific OTC Antihistamine Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific OTC Antihistamine Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America OTC Antihistamine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America OTC Antihistamine Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America OTC Antihistamine Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa OTC Antihistamine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa OTC Antihistamine Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa OTC Antihistamine Market Size by Country (2026-2031) & (US$ Million)
Table 47. Merck Company Details
Table 48. Merck Business Overview
Table 49. Merck OTC Antihistamine Product
Table 50. Merck Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 51. Merck Recent Development
Table 52. Pfizer Company Details
Table 53. Pfizer Business Overview
Table 54. Pfizer OTC Antihistamine Product
Table 55. Pfizer Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Bayer Company Details
Table 58. Bayer Business Overview
Table 59. Bayer OTC Antihistamine Product
Table 60. Bayer Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 61. Bayer Recent Development
Table 62. Teva Company Details
Table 63. Teva Business Overview
Table 64. Teva OTC Antihistamine Product
Table 65. Teva Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 66. Teva Recent Development
Table 67. Cadila Pharmaceuticals Company Details
Table 68. Cadila Pharmaceuticals Business Overview
Table 69. Cadila Pharmaceuticals OTC Antihistamine Product
Table 70. Cadila Pharmaceuticals Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 71. Cadila Pharmaceuticals Recent Development
Table 72. PAI Pharma Company Details
Table 73. PAI Pharma Business Overview
Table 74. PAI Pharma OTC Antihistamine Product
Table 75. PAI Pharma Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 76. PAI Pharma Recent Development
Table 77. Dr. Reddy's Laboratories Company Details
Table 78. Dr. Reddy's Laboratories Business Overview
Table 79. Dr. Reddy's Laboratories OTC Antihistamine Product
Table 80. Dr. Reddy's Laboratories Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 81. Dr. Reddy's Laboratories Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson OTC Antihistamine Product
Table 85. Johnson & Johnson Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. SANOFI Company Details
Table 88. SANOFI Business Overview
Table 89. SANOFI OTC Antihistamine Product
Table 90. SANOFI Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 91. SANOFI Recent Development
Table 92. PL Developments Company Details
Table 93. PL Developments Business Overview
Table 94. PL Developments OTC Antihistamine Product
Table 95. PL Developments Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 96. PL Developments Recent Development
Table 97. APOTEX Company Details
Table 98. APOTEX Business Overview
Table 99. APOTEX OTC Antihistamine Product
Table 100. APOTEX Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 101. APOTEX Recent Development
Table 102. Morepen Company Details
Table 103. Morepen Business Overview
Table 104. Morepen OTC Antihistamine Product
Table 105. Morepen Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 106. Morepen Recent Development
Table 107. Ultratech India Company Details
Table 108. Ultratech India Business Overview
Table 109. Ultratech India OTC Antihistamine Product
Table 110. Ultratech India Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 111. Ultratech India Recent Development
Table 112. Vasudha Pharma Chem Company Details
Table 113. Vasudha Pharma Chem Business Overview
Table 114. Vasudha Pharma Chem OTC Antihistamine Product
Table 115. Vasudha Pharma Chem Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 116. Vasudha Pharma Chem Recent Development
Table 117. Hetero Drugs Company Details
Table 118. Hetero Drugs Business Overview
Table 119. Hetero Drugs OTC Antihistamine Product
Table 120. Hetero Drugs Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 121. Hetero Drugs Recent Development
Table 122. Mylan Company Details
Table 123. Mylan Business Overview
Table 124. Mylan OTC Antihistamine Product
Table 125. Mylan Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 126. Mylan Recent Development
Table 127. Changzhou Yabang Company Details
Table 128. Changzhou Yabang Business Overview
Table 129. Changzhou Yabang OTC Antihistamine Product
Table 130. Changzhou Yabang Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 131. Changzhou Yabang Recent Development
Table 132. Shaanxi Hanjiang Company Details
Table 133. Shaanxi Hanjiang Business Overview
Table 134. Shaanxi Hanjiang OTC Antihistamine Product
Table 135. Shaanxi Hanjiang Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 136. Shaanxi Hanjiang Recent Development
Table 137. Inke, S.A. Company Details
Table 138. Inke, S.A. Business Overview
Table 139. Inke, S.A. OTC Antihistamine Product
Table 140. Inke, S.A. Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 141. Inke, S.A. Recent Development
Table 142. Argon Drugs Company Details
Table 143. Argon Drugs Business Overview
Table 144. Argon Drugs OTC Antihistamine Product
Table 145. Argon Drugs Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 146. Argon Drugs Recent Development
Table 147. Covis Pharma Company Details
Table 148. Covis Pharma Business Overview
Table 149. Covis Pharma OTC Antihistamine Product
Table 150. Covis Pharma Revenue in OTC Antihistamine Business (2020-2025) & (US$ Million)
Table 151. Covis Pharma Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
Table 155. Authors List of This Report
List of Figures
Figure 1. OTC Antihistamine Picture
Figure 2. Global OTC Antihistamine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global OTC Antihistamine Market Share by Type: 2024 VS 2031
Figure 4. Oral Solution Features
Figure 5. Tablet Features
Figure 6. Capsule Features
Figure 7. Global OTC Antihistamine Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global OTC Antihistamine Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Drug Store Case Studies
Figure 12. OTC Antihistamine Report Years Considered
Figure 13. Global OTC Antihistamine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global OTC Antihistamine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global OTC Antihistamine Market Share by Region: 2024 VS 2031
Figure 16. Global OTC Antihistamine Market Share by Players in 2024
Figure 17. Global Top OTC Antihistamine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Antihistamine as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by OTC Antihistamine Revenue in 2024
Figure 19. North America OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America OTC Antihistamine Market Share by Country (2020-2031)
Figure 21. United States OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe OTC Antihistamine Market Share by Country (2020-2031)
Figure 25. Germany OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific OTC Antihistamine Market Share by Region (2020-2031)
Figure 33. China OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America OTC Antihistamine Market Share by Country (2020-2031)
Figure 41. Mexico OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa OTC Antihistamine Market Share by Country (2020-2031)
Figure 45. Turkey OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE OTC Antihistamine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Merck Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 50. Bayer Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 51. Teva Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 52. Cadila Pharmaceuticals Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 53. PAI Pharma Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 54. Dr. Reddy's Laboratories Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 55. Johnson & Johnson Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 56. SANOFI Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 57. PL Developments Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 58. APOTEX Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 59. Morepen Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 60. Ultratech India Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 61. Vasudha Pharma Chem Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 62. Hetero Drugs Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 63. Mylan Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 64. Changzhou Yabang Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 65. Shaanxi Hanjiang Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 66. Inke, S.A. Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 67. Argon Drugs Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 68. Covis Pharma Revenue Growth Rate in OTC Antihistamine Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Krypton Flash Lamp Market Research Report 2025
May 12, 25
Global IR Halogen Lamp Market Research Report 2025
May 12, 25
Global Halogen IR Lamp Market Research Report 2025
May 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232